Zipeng Xu
Papers
1
Total Citations
24
H-Index
1
About
Dr. Zipeng Xu is a leading surgical oncologist whose research focuses on advanced gastric cancer treatment, particularly the optimization of robotic-assisted gastrectomy techniques. His major contribution lies in systematically evaluating the safety and feasibility of robot-assisted total gastrectomy (RATG) compared to distal gastrectomy (RADG) for advanced gastric cancer. In his landmark 2019 study, which has garnered 24 citations, Dr. Xu employed the rigorous Clavien–Dindo classification to retrospectively assess postoperative complications in a propensity score-matched cohort. This work provided critical evidence that RATG, despite its technical challenges, can be performed with acceptable morbidity, helping to expand surgical options for patients requiring total gastrectomy. By clarifying complication profiles and operative outcomes, Dr. Xu’s research directly informs clinical decision-making and surgical training. His meticulous approach to outcomes assessment has established benchmarks for robotic gastric cancer surgery, influencing both practice guidelines and future prospective studies. Dr. Xu’s ongoing work continues to refine minimally invasive techniques, aiming to improve recovery and survival for gastric cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1